|
GleevecDrug - Gleevec The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Imatinib Mesylate
Strength -
100MG
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
021588
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Apr 18, 2003
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Novartis Pharmaceuticals Corp
Gleevec
Ifosfamide 3gm/vial Injectable; Injection
Ifex/mesnex Kit 1gm/vial;100mg/ml Injectable; Injection Ifex/mesnex Kit 3gm/vial;100mg/ml Injectable; Injection Ifosfamide/mesna Kit Eq 1gm /20ml(50mg/ml);eq 1gm /10ml(100mg/ml) Injectable; Intravenous Ifosfamide/mesna Kit Eq 3gm /60ml(50mg/ml);eq 1gm /10ml(100mg/ml) Injectable; Intravenous Ventavis 20ugm/2ml (10ugm/ml) Solution; Inhalation Gleevec 100mg Capsule; Oral Gleevec 50mg Capsule; Oral Gleevec 100mg Tablet; Oral Ifosfamide 1gm/vial Injectable; Injection NewDrugInformation |